Article Information
PMID
Published By
Print ISSN
1109-6535
Online ISSN
1790-6245
History
- Received April 11, 2023
- Revision received June 9, 2023
- Accepted June 19, 2023
- Published online July 3, 2023.
Copyright & License
Copyright © 2023 The Author(s). Published by the International Institute of Anticancer Research. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY-NC-ND) 4.0 international license (https://creativecommons.org/licenses/by-nc-nd/4.0).
Author Information
- HAJIME SHIGETO1,*,
- HARUO MIYATA2,*,
- TADASHI ASHIZAWA2,
- AKIRA IIZUKA2,
- YASUFUMI KIKUCHI2,
- CHIKAKO HOZUMI2,
- CHIE MAEDA2,
- KEN YAMAGUCHI3,
- SHOHEI YAMAMURA1 and
- YASUTO AKIYAMA2⇑
- 1Health and Medical Research Institute, National Institute of Advanced Industrial Science and Technology (AIST), Kagawa, Japan;
- 2Immunotherapy Division, Shizuoka Cancer Center Research Institute, Shizuoka, Japan;
- 3Shizuoka Cancer Center, Shizuoka, Japan
- Correspondence to: Yasuto Akiyama, MD, Immunotherapy Division, Shizuoka Cancer Center Research Institute, 1007 Shimonagakubo, Nagaizumi-cho, Sunto-gun, Shizuoka 411-8777, Japan. Tel.: +81 559895222 (Ext. 5330), Fax: +81 559896085, e-mail: y.akiyama{at}scchr.jp






